Oncimmune secures €8.5m credit facility from IPF Management

Fri, 20th Sep 2019

Immunodiagnostics group Oncimmune said it had secured a new €8.5m credit facility from IPF Management. Oncimmune said it would immediately draw down an initial €5m with the remaining €3.5m to be drawn down within six months. The facility was for a four-year term, though it could be repaid early. Proceeds would be used to drive the commercial adoption of the company's EarlyCDT Lung cancer diagnosis technology. 'The facility will fund the company into 2021, giving the company a solid runway to drive the commercialisation of its products and services,' Oncimmune said. Story provided by StockMarketWire.com

FTSE 100 Latest
Value7,308.61
Change70.06